Professional Documents
Culture Documents
Cholinesterase Inhibitors - Alzheimers
Cholinesterase Inhibitors - Alzheimers
Cholinesterase Inhibitors/Anticholinesterase
Identifying high risk Caution in patients with asthma Anesthesia, sick sinus rhythm, AV block, bradycardia, cardiac
patients or COPD. arrhythmias, cardiac disease, hypotension; hyperthyroidism, history
of ulcers, abnormal liver function; patients with asthma or
obstructive pulmonary disease, history of seizures, seizures, urinary
tract obstruction, intestinal obstruction; diarrhea, emesis, GI disease,
renal failure, renal impairment, surgery.
Administration Dosage should be low initially Three oral formulation, standard tablets (5 & 10 mg), disintegrating
Routes and then gradually increased to tablets (5 & 10 mg) and a solution (1 mg/mL)
Dosage the highest tolerable amount.
Done late in the evening, with/out food.
Patient Education
GI effects- nausea, vomiting, Fainting episodes related to slowing the heart rate may occur.
dyspepsia, diarrhea.
Report if any GI ulceration or bleeding (“coffee grounds” emesis,
Dizziness & headache are tarry stools, epigastric pain)
common.
Nausea, diarrhea, headache, fatigue
Cause bronchoconstriction—
especially in asthmatic and Do not use if pregnant, lactating, GI bleeding, or jaundice
COPD
CNS: Insomnia, dizziness, depression, tremor, irritability, vertigo,
ataxia.
CV: Syncope, hypertension, atrial fibrillation, hot flashes,
hypotension.
GI: Nausea, diarrhea, vomiting, muscle cramps, anorexia, GI
bleeding, bloating, fecal incontinence, epigastric pain.
Respiratory: Dyspnea.
Skin: Pruritus, sweating, urticaria.
Other: Ecchymoses, muscle cramps, dehydration, blurred vision,
urinary incontinence, nocturia.